You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

DECA-DURABOLIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Deca-durabolin patents expire, and when can generic versions of Deca-durabolin launch?

Deca-durabolin is a drug marketed by Woodward Specl and is included in one NDA.

The generic ingredient in DECA-DURABOLIN is nandrolone decanoate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone decanoate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DECA-DURABOLIN?
  • What are the global sales for DECA-DURABOLIN?
  • What is Average Wholesale Price for DECA-DURABOLIN?
Summary for DECA-DURABOLIN
Drug patent expirations by year for DECA-DURABOLIN
Recent Clinical Trials for DECA-DURABOLIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Morten Tange Kristensen PT, PhDPhase 2
University Hospital OstravaN/A

See all DECA-DURABOLIN clinical trials

US Patents and Regulatory Information for DECA-DURABOLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Woodward Specl DECA-DURABOLIN nandrolone decanoate INJECTABLE;INJECTION 013132-001 Jun 12, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Woodward Specl DECA-DURABOLIN nandrolone decanoate INJECTABLE;INJECTION 013132-002 Jun 12, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Woodward Specl DECA-DURABOLIN nandrolone decanoate INJECTABLE;INJECTION 013132-003 Jun 12, 1986 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

DECA-DURABOLIN Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of DECA-DURABOLIN (Nandrolone Decanoate)

Introduction

DECA-DURABOLIN, also known as Nandrolone Decanoate, is a widely used anabolic steroid with significant applications in both medical and sports sectors. This article delves into the market dynamics, financial trajectory, and key factors influencing the growth of the Nandrolone Decanoate market.

Market Size and Growth

The Nandrolone Decanoate market has shown robust growth in recent years. As of 2023, the market size was valued at USD 100 billion and is projected to reach USD 140.71 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 5% from 2024 to 2031[1].

Market Segmentation

The market is segmented based on type, application, and geography.

Type

  • Injectable Grade: This is the most common form of Nandrolone Decanoate, used for both medical and sports purposes.
  • Pharmaceutical Grade: Used in the production of prescription medications.
  • Research Grade: Utilized in scientific research and development.

Application

  • Anabolic Steroids: For muscle building and performance enhancement.
  • Muscle Building: Popular among bodybuilders and athletes.
  • Hormone Therapy: Used to treat hormonal imbalances and conditions such as osteoporosis.
  • Sports Medicine: To enhance physical performance and aid in recovery.

Geography

The market is spread across North America, Europe, Asia-Pacific, South America, and the Middle East & Africa, with varying demand and growth rates in each region[1].

Key Drivers of Market Growth

Several factors are driving the growth of the Nandrolone Decanoate market.

Medical Applications

Nandrolone Decanoate is used to treat various medical conditions, including anemia, osteoporosis, and chronic illnesses. Its therapeutic benefits, such as improving muscle mass and alleviating joint pain, are significant drivers of market growth[1][4].

Sports and Fitness

The increasing trend of fitness and sports activities globally has led to a higher demand for performance-enhancing medications. Nandrolone Decanoate's effectiveness in enhancing physical performance and muscle retention makes it a popular choice among athletes and bodybuilders[1][5].

Regulatory Approvals and Pharmaceutical Developments

Advancements in pharmaceutical technology, such as innovative formulations and drug delivery methods, have improved the efficacy and attractiveness of Nandrolone Decanoate. Regulatory approvals and supportive policies also contribute to market expansion[1].

Global Health Awareness

Growing global awareness of healthcare and the importance of physical fitness are additional factors driving the demand for Nandrolone Decanoate. As more people become health-conscious, the market for both medicinal and performance-enhancing products is expected to grow[1].

Market Challenges and Considerations

While the market is growing, there are several challenges and considerations to note.

Regulatory Restrictions

Nandrolone Decanoate is classified as a restricted substance in many countries, including Australia, where it is listed under Appendix D of the Australian Poisons and Therapeutic Goods Regulation 2008. This can limit its availability and use in certain regions[2].

Side Effects and Contraindications

The drug has several contraindications, including pregnancy, breastfeeding, and hypersensitivity to the active substance or excipients. It also requires careful monitoring for side effects such as polycythemia, tumors, and cardiac, renal, or hepatic insufficiency[4].

Misuse and Abuse

The potential for misuse and abuse, particularly in the sports sector, is a significant concern. This can lead to regulatory scrutiny and public health issues[5].

Financial Trajectory

The financial trajectory of the Nandrolone Decanoate market is promising, driven by increasing demand and expanding applications.

Revenue Projections

The market is expected to grow from USD 100 billion in 2023 to USD 140.71 billion by 2031, indicating a steady and significant increase in revenue over the forecast period[1].

Key Players

Several key companies are profiled in the market, including Organon International, Pfizer Inc., Gen-Shi Laboratories, Dragon Pharma, and others. These companies play a crucial role in the production, distribution, and innovation within the market[1].

Market Trends and Innovations

The market is witnessing several trends and innovations that are shaping its future.

Pharmaceutical Innovations

Advancements in pharmaceutical formulations and drug delivery methods are enhancing the efficacy and safety of Nandrolone Decanoate. These innovations are expected to continue driving market growth[1].

Regulatory Support

Supportive regulatory environments and policies are crucial for the market's expansion. Changes in regulatory policies can significantly impact the market dynamics and growth trajectory[3].

Global Health Trends

The global trend towards better health and fitness is a key driver of the market. As more people engage in sports and fitness activities, the demand for performance-enhancing medications like Nandrolone Decanoate is expected to rise[1].

Conclusion

The Nandrolone Decanoate market is poised for significant growth, driven by its diverse applications in medicine and sports, advancements in pharmaceutical technology, and increasing global health awareness. However, it is crucial to address the challenges related to regulatory restrictions, side effects, and potential misuse.

Key Takeaways

  • The Nandrolone Decanoate market is projected to reach USD 140.71 billion by 2031, growing at a 5% CAGR.
  • The market is driven by medical applications, sports and fitness trends, and pharmaceutical innovations.
  • Regulatory approvals and global health awareness are key factors influencing market growth.
  • The market faces challenges such as regulatory restrictions, side effects, and potential misuse.
  • Key players in the market include Organon International, Pfizer Inc., and others.

FAQs

What are the primary applications of Nandrolone Decanoate?

Nandrolone Decanoate is primarily used in anabolic steroids, muscle building, hormone therapy, and sports medicine.

What is the expected market size of Nandrolone Decanoate by 2031?

The market is expected to reach USD 140.71 billion by 2031.

What are the key drivers of the Nandrolone Decanoate market?

Key drivers include medical applications, sports and fitness trends, pharmaceutical innovations, and global health awareness.

What are the common side effects and contraindications of Nandrolone Decanoate?

Common side effects include polycythemia, tumors, and cardiac, renal, or hepatic insufficiency. Contraindications include pregnancy, breastfeeding, and hypersensitivity to the active substance or excipients.

Which companies are major players in the Nandrolone Decanoate market?

Major players include Organon International, Pfizer Inc., Gen-Shi Laboratories, Dragon Pharma, and others.

Sources

  1. Market Research Intellect: Nandrolone Decanoate Market Size, Share, Trends, Analysis, 2031.
  2. TestoChecker: What's in Sustanon 250 and Deca Durabolin?
  3. Federal Trade Commission: Generic Drug Industry Dynamics.
  4. Drugs.com: DECA-DURABOLIN 50MG/ML INJECTION - Drugs.com.
  5. John Doe Bodybuilding: Deca Durabolin 101: All About Nandrolone Decanoate.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.